The Cybersecurity and Infrastructure Security Agency yesterday alerted organizations to a global phishing and spearphishing campaign targeting the COVID-19 vaccine cold chain, the part of the supply chain used to store and transport a vaccine at safe temperatures. According to an IBM X-Force report, cyber actors impersonating a biomedical company have sent emails to executives and global organizations involved in COVID-19 vaccine storage and transport to harvest credentials. The emails have posed as requests for quotations to participate in a vaccine program. CISA encourages organizations to review the report for more information.

John Riggi, AHA senior advisor for cyber and risk, said, “This alert demonstrates the need to remain vigilant and educate staff of the perils of phishing emails, the number one attack vector by cyber adversaries, because frankly it works and is fairly simple. However, the impact of clicking on a phishing email in the context of vaccine distribution could have broad public health implications.”

For more on cybersecurity and risk issues, hospital and health system leaders may contact Riggi at jriggi@aha.org.

Related News Articles

Headline
Two AHA guides offer strategies for hospitals and health systems in preparing for public health emergencies and disasters and managing cybersecurity incidents…
Headline
Larry Pierce, director of cybersecurity and information security officer for Atlantic Health, unpacks how the growth of artificial intelligence is reshaping…
Headline
U.S. and international agencies Jan. 14 released guidance on secure connectivity for operational technology environments. Examples of OT environments in health…
Headline
The AHA Jan. 14 expressed support for the Rural Hospital Cybersecurity Enhancement Act (S. 2169), legislation that would direct the Department of Health and…
Headline
The FBI Jan. 8 released an alert on evolving threat tactics by Kimsuky, a North Korean state-sponsored cyber threat group. As of last year, the group…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…